You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR BLOXIVERZ


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for BLOXIVERZ

Trial ID Title Status Sponsor Phase Start Date Summary
NCT05887375 ↗ Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery Not yet recruiting Merck Sharp & Dohme LLC Phase 4 2023-07-01 This is an active-comparator controlled study to evaluate the effect of sugammadex compared to neostigmine/glycopyrrolate for reversal of rocuronium on the incidence of urinary retention after subjects undergo elective ambulatory spine surgery.
NCT05887375 ↗ Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery Not yet recruiting University of Missouri-Columbia Phase 4 2023-07-01 This is an active-comparator controlled study to evaluate the effect of sugammadex compared to neostigmine/glycopyrrolate for reversal of rocuronium on the incidence of urinary retention after subjects undergo elective ambulatory spine surgery.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for BLOXIVERZ

Condition Name

Condition Name for BLOXIVERZ
Intervention Trials
Reversal of Neuromuscular Blockade 1
Spine Surgery 1
Urinary Retention Postoperative 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for BLOXIVERZ
Intervention Trials
Urinary Retention 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for BLOXIVERZ

Clinical Trial Phase

Clinical Trial Phase for BLOXIVERZ
Clinical Trial Phase Trials
Phase 4 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for BLOXIVERZ
Clinical Trial Phase Trials
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for BLOXIVERZ

Sponsor Name

Sponsor Name for BLOXIVERZ
Sponsor Trials
Merck Sharp & Dohme LLC 1
University of Missouri-Columbia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for BLOXIVERZ
Sponsor Trials
Industry 1
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.